Back
Ultra Clean Holdings Vs. Monopar Therapeutics Industry Stock Comparison
Sell
33
UCTT
Ultra Clean Holdings
Last Price:
$24.25
Seasonality Move:
6.53%
Buy
51
MNPR
Monopar Therapeutics
Last Price:
$41.15
Seasonality Move:
-13.48%
Sell
33
Ultra Clean Holdings (UCTT)
is a Sell
Is Ultra Clean Holdings a Buy, Sell or Hold?
-
The current Ultra Clean Holdings [UCTT] share price is $24.25. The Score for UCTT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.00. The Score for MNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UCTT Stock Price Chart
What is Ultra Clean Holdings's stock price today?
-
The Ultra Clean Holdings share price today is $24.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight selling pressure.
UCTT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.56 | Sell |
| Relative Strength Index (14 RSI): | 35.1 | Sell |
| Chaikin Money Flow: | 112470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.38 - 34.42) | Sell |
| Bollinger Bands (100): | (29.8 - 39.64) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 57.07 | Buy |
| Chaikin Money Flow: | -8240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.7 - 42.4) | Buy |
| Bollinger Bands (100): | (18.31 - 38.87) | Buy |
UCTT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.84 | Sell |
| 20-day SMA: | 26.02 | Sell |
| 50-day SMA: | 32.85 | Sell |
| 200-day SMA: | 38.33 | Sell |
| 8-day EMA: | 24.83 | Sell |
| 20-day EMA: | 26.81 | Sell |
| 50-day EMA: | 30.84 | Sell |
| 200-day EMA: | 36.02 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.32 | Buy |
| 20-day SMA: | 33.72 | Buy |
| 50-day SMA: | 36.44 | Buy |
| 200-day SMA: | 16.17 | Buy |
| 8-day EMA: | 36.98 | Buy |
| 20-day EMA: | 35.79 | Buy |
| 50-day EMA: | 34.28 | Buy |
| 200-day EMA: | 20.85 | Buy |
Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Ultra Clean Holdings Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||